Autolus Therapeutics plc American Depositary Share
N/A
USD
N/A
N/A
...
Chart
Financials
Description
AUTL Company Description
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.
AUTL Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view AUTL Smart Score
Score Breakdown
AUTL Company Description
Show More
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8. Show Less
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of AUTL by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by AUTL's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
Twitter
Followers on AUTL's company Twitter account
WallStreetBets
Number of mentions of AUTL in WallStreetBets Daily Discussion
AUTL News
Recent insights relating to AUTL
CNBC Recommendations
Recent picks made for AUTL stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in AUTL
Corporate Flights
Flights by private jets registered to AUTL
Our Analysis